Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ovarian Neoplasms

  Free Subscription


2 Anticancer Drugs
3 Br J Cancer
1 Cancer
6 Gynecol Oncol
1 J Natl Cancer Inst

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Anticancer Drugs

  1. WEI S, Qi L, Wang L
    Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
    Anticancer Drugs. 2021 Mar 16. pii: 00001813-900000000-98432.
    PubMed         Abstract available

  2. HU H, Zhu S, Tong Y, Huang G, et al
    Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro.
    Anticancer Drugs. 2020;31:483-491.
    PubMed         Abstract available

    Br J Cancer

  3. LEPAGE CC, Palmer MCL, Farrell AC, Neudorf NM, et al
    Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer.
    Br J Cancer. 2021 Mar 17. pii: 10.1038/s41416-021-01317.
    PubMed         Abstract available

  4. ZHANG X, Ling MT, Feng H, Wong YC, et al
    Retraction Note to: Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells.
    Br J Cancer. 2021 Mar 15. pii: 10.1038/s41416-021-01322.

  5. MONTFORT A, Owen S, Piskorz AM, Supernat A, et al
    Combining measures of immune infiltration shows additive effect on survival prediction in high-grade serous ovarian carcinoma.
    Br J Cancer. 2020 Apr 6. pii: 10.1038/s41416-020-0822.
    PubMed         Abstract available


  6. LEE CK, Friedlander ML, Tjokrowidjaja A, Ledermann JA, et al
    Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
    Cancer. 2021 Mar 19. doi: 10.1002/cncr.33517.
    PubMed         Abstract available

    Gynecol Oncol

  7. BUECHEL ME, Enserro D, Burger RA, Brady MF, et al
    Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
    Gynecol Oncol. 2021 Mar 9. pii: S0090-8258(21)00177.
    PubMed         Abstract available

  8. LAGO V, Montero B, Lopez S, Padilla-Iserte P, et al
    Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer.
    Gynecol Oncol. 2021 Mar 9. pii: S0090-8258(21)00193.
    PubMed         Abstract available

  9. MORDEN CR, Farrell AC, Sliwowski M, Lichtensztejn Z, et al
    Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples.
    Gynecol Oncol. 2021 Mar 10. pii: S0090-8258(21)00199.
    PubMed         Abstract available

  10. ROCCONI RP, Monk BJ, Walter A, Herzog TJ, et al
    Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer.
    Gynecol Oncol. 2021 Mar 11. pii: S0090-8258(21)00229.
    PubMed         Abstract available

  11. HASSELGREN E, Hertzberg D, Camderman T, Bjorne H, et al
    Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer.
    Gynecol Oncol. 2021 Mar 12. pii: S0090-8258(21)00179.
    PubMed         Abstract available

  12. LOREEN A, Polen-De C, Monk BJ, Jackson AL, et al
    The role of blinded independent radiologic review in ovarian cancer clinical trials: Discerning the value.
    Gynecol Oncol. 2021 Mar 12. pii: S0090-8258(21)00176.

    J Natl Cancer Inst

  13. WENZEL L, Osann K, McKinney C, Cella D, et al
    Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.
    J Natl Cancer Inst. 2021 Mar 17. pii: 6174697. doi: 10.1093.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.